Does CANRENOATE Cause Hypervolaemia? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hypervolaemia have been filed in association with CANRENOATE. This represents 1.6% of all adverse event reports for CANRENOATE.
7
Reports of Hypervolaemia with CANRENOATE
1.6%
of all CANRENOATE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Hypervolaemia From CANRENOATE?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOATE Cause?
Hyperkalaemia (96)
Acute kidney injury (63)
Toxic epidermal necrolysis (58)
Hyponatraemia (52)
Off label use (45)
Dehydration (39)
Hypotension (39)
Drug hypersensitivity (37)
Dyspnoea (36)
Asthenia (33)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
Which CANRENOATE Alternatives Have Lower Hypervolaemia Risk?
CANRENOATE vs CANRENOIC ACID
CANRENOATE vs CANRENONE
CANRENOATE vs CANTHARIDIN
CANRENOATE vs CAPECITABINE
CANRENOATE vs CAPIVASERTIB